Finance

Lists
Why is SMNR down 22,33%?
Dive Deeper
SMNR:OTCMKTS
Semnur Pharmaceuticals Inc
0,40 $
-22,33%
(-0,11) 1D
16 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMNR...
Open
0,51 $
High
0,52 $
Low
0,39 $
Mkt. cap
91,20 մլն
Avg. vol.
4,24 հզր
Volume
772,00
52-wk high
23,00 $
52-wk low
0,13 $
Beta
-109,28
Shares outstanding
230,21 մլն
No. of employees
5
Open
0,51 $
High
0,52 $
Low
0,39 $
Mkt. cap
91,20 մլն
Avg. vol.
4,24 հզր
Volume
772,00
52-wk high
23,00 $
52-wk low
0,13 $
Beta
-109,28
Shares outstanding
230,21 մլն
No. of employees
5
News stories
From web sources and news partners
About Semnur Pharmaceuticals Inc
CEO-
Employees5
Founded2013
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,14 մլն
714,00 հզր
1,27 մլն
1,25 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
151,45 մլն
5,44 մլն
3,31 մլն
2,98 մլն
Operating expense
152,59 մլն
6,16 մլն
4,58 մլն
4,22 մլն
Total operating expenses
152,59 մլն
6,16 մլն
4,58 մլն
4,22 մլն
Operating income
-152,59 մլն
-6,16 մլն
-4,58 մլն
-4,22 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-152,59 մլն
-6,16 մլն
-4,58 մլն
-4,35 մլն
EBT excluding unusual items
-152,59 մլն
-6,16 մլն
-4,58 մլն
-4,35 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-152,59 մլն
-6,16 մլն
-4,58 մլն
-4,35 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-123,00 հզր
Net interest expenses
-
-
-
-123,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps